UNSPSC 85814815: Introduction of liquid brachytherapy radioisotope into male reproductive, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of liquid brachytherapy radioisotope into male reproductive, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0N804

UNSPSC 85814815, Introduction of liquid brachytherapy radioisotope into male reproductive via natural or artificial opening endoscopic, is a Commodity code that appears to show minimal alignment with recent state and local procurement activity. The recent opportunities tagged to this code do not involve brachytherapy, radioisotope administration, or urological procedures; instead, they span telehealth urgent care, occupational health services, cancer screening, employee wellness platforms, opioid use disorder treatment, behavioral health services, and medical staffing across a broad range of state and local agencies.

The issuing bodies represent a typical state and local mix—county health systems (Santa Clara, Brevard, DeKalb), state health authorities (Nevada, Colorado, Texas), municipal fire and EMS departments (Atlanta, Sarasota, Boulder), school districts (Parkway), cities (Phoenix, Ocala, Atlanta), and specialized authorities (Inland Empire Health Plan in California, Events DC). Geographic spread spans California, Georgia, Nevada, Colorado, Texas, Illinois, Florida, Oregon, Kansas, and New York. Representative opportunities include the Nevada Health Authority's RFP for Program of All Inclusive Care for the Elderly (proposals due December 10, 2026), Inland Empire Health Plan's RFI for virtual urgent care services (October 31, 2026), and San Mateo County's RFP for cancer registry and handheld retinal screening services (November 6, 2026). None of these opportunities directly relate to brachytherapy or urological radioisotope therapy. The code shows little to no recent relevant procurement activity; the mismatch between the code's nominal scope and what state and local governments are actually buying under this tag makes the code a poor targeting candidate for business development purposes.